Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study comparing lower immunosuppression versus traditional immunosuppression in heart transplant recipients to evaluate safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Newark Beth Israel Medical Center | Conditions: Immunosuppression | Phase 4 | Status: COMPLETED | Results posted: 2015-05-28